New imaging tool is better at detecting the signs of fetal alcohol syndrome.

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

Amid allegations of malpractice and poor oversight, the country’s healthcare industry is determined to make clinical trials safer and more effective.

A new study suggests that carotenoid-producing aphids may be the only animals capable of harnessing the energy of the sun in a process similar to plants.

A polar bear in a German zoo dies after contracting a virus normally found in zebras.

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.

A study suggests that increased UVB radiation from the sun is behind the decline of many marine species.

An appeals court dismisses the case of a tenured law professor who was challenging her 2006termination.

Opponents of a new law requiring government researchers to publicly disclose personal financial information claim it is an invasion of privacy.

An advocacy group claims that heroin addicts participating in a Chinese study were not in a position to give their informed consent.